SCHEMBL31423913

SCHEMBL31423913

CC[C@@H](C)Nc1nc2c(N3CC4CC3C4)c(-c3cn[nH]c3)ncn2n1

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.30
FLT3 P36888 1/20 0.30
TYRO3 Q06418 1/20 0.30
MERTK Q12866 1/20 0.30
MAPK8 P45983 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423900 0.92
SCHEMBL31423888 0.92
SCHEMBL31423941 0.91 MAPK8 (0.38) MAPK8
SCHEMBL31423945 0.91 MAPK8 (0.38) MAPK8
SCHEMBL31423987 0.84 JAK2 (0.38)
SCHEMBL31423957 0.79
SCHEMBL31423991 0.79
SCHEMBL31423935 0.79
SCHEMBL31423985 0.79
SCHEMBL31423982 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025054386-A1 CDK2 INHIBITORS AND USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2025-03-13 WO disclosed